- Home
- BROS vs LNTH Comparison
BROS vs LNTH Comparison
Compare BROS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BROS | LNTH |
|---|---|---|
| Founded | 1992 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 4.4B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BROS | LNTH |
|---|---|---|
| Price | $64.49 | $65.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 6 |
| Target Price | $77.16 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 3.3M | 1.1M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.73 | N/A |
| EPS | 0.51 | ★ 2.39 |
| Revenue | ★ $1,537,335,000.00 | $1,525,933,000.00 |
| Revenue This Year | $28.73 | $0.01 |
| Revenue Next Year | $25.41 | $1.24 |
| P/E Ratio | $128.42 | ★ $27.10 |
| Revenue Growth | ★ 28.93 | 1.95 |
| 52 Week Low | $47.16 | $47.25 |
| 52 Week High | $86.88 | $111.29 |
Technical Indicators
Market Signals| Indicator | BROS | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 67.37 | 67.49 |
| Support Level | $60.25 | $64.13 |
| Resistance Level | $65.93 | $67.01 |
| Average True Range (ATR) | 1.94 | 2.14 |
| MACD | 0.51 | 0.33 |
| Stochastic Oscillator | 84.52 | 85.42 |
Price Performance
Historical ComparisonAbout BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.